FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377011454> ?p ?o ?g. }

• W4377011454 abstract "Abstract Early access programs (EAPs) generally refer to patient access to medicines/indications before marketing authorization, possibly extended to price and reimbursement approval. These programs include compassionate use, which is usually covered by pharmaceutical companies, and EAPs reimbursed by third-party payers. This paper aims at comparing EAPs in four European countries (France, Italy, Spain, UK) and providing empirical evidence on EAPs in Italy. The comparative analysis was conducted through a literature review (including scientific and grey literature), complemented by 30-min semi-structured interviews with local experts. The Italian empirical analysis employed data available on the National Medicines Agency website. Although EAPs are very different across countries, they exhibit some common features: (i) eligibility criteria refer to the absence of valid therapeutic alternatives and a presumed favourable risk–benefit profile; (ii) payers do not allocate a pre-determined budget to these programs; (iii) total spending on EAPs is unknown. The French EAPs seem to be the most structured, financed through social insurance, covering pre-marketing, post-marketing and pre-reimbursement phases and providing for data collection. Italy’s approach to EAPs has been varied, with several programs covered by different payers, including the cohort-based 648 List (for both early access and off-label use), the nominal-based 5% Fund, and Compassionate Use. Most applications to EAPs are from the Antineoplastic and immunomodulating drug class (ATC L). Some 62% of indications in the 648 List are either not under clinical development or have never been approved (pure off-label use). For those subsequently approved, most approved indications coincide with those covered through EAPs. Only the 5% Fund provides data on economic impact (€ 81.2 million in 2021; average cost per patient € 61.5K). Diverse EAPs are a possible source of inequalities in access to medicines across Europe. A harmonization of these programs, though difficult to achieve, could be modelled on the French EAPs and provide key advantages, not least of which a common effort to collect real-world data in parallel with clinical trials and clear separation between EAPs and off-label use programs." @default.
• W4377011454 created "2023-05-19" @default.
• W4377011454 creator A5014015863 @default.
• W4377011454 creator A5016594838 @default.
• W4377011454 creator A5041626117 @default.
• W4377011454 creator A5068114387 @default.
• W4377011454 creator A5071078329 @default.
• W4377011454 creator A5083810753 @default.
• W4377011454 date "2023-05-17" @default.
• W4377011454 modified "2023-10-13" @default.
• W4377011454 title "Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case" @default.
• W4377011454 cites W1980186242 @default.
• W4377011454 cites W2037887365 @default.
• W4377011454 cites W2115854144 @default.
• W4377011454 cites W2124241434 @default.
• W4377011454 cites W2212551923 @default.
• W4377011454 cites W2236060003 @default.
• W4377011454 cites W2245295092 @default.
• W4377011454 cites W2891605369 @default.
• W4377011454 cites W2951427697 @default.
• W4377011454 cites W3143340203 @default.
• W4377011454 cites W3213754017 @default.
• W4377011454 cites W4205258011 @default.
• W4377011454 doi "https://doi.org/10.1186/s40545-023-00570-z" @default.
• W4377011454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37198599" @default.
• W4377011454 hasPublicationYear "2023" @default.
• W4377011454 type Work @default.
• W4377011454 citedByCount "1" @default.
• W4377011454 crossrefType "journal-article" @default.
• W4377011454 hasAuthorship W4377011454A5014015863 @default.
• W4377011454 hasAuthorship W4377011454A5016594838 @default.
• W4377011454 hasAuthorship W4377011454A5041626117 @default.
• W4377011454 hasAuthorship W4377011454A5068114387 @default.
• W4377011454 hasAuthorship W4377011454A5071078329 @default.
• W4377011454 hasAuthorship W4377011454A5083810753 @default.
• W4377011454 hasBestOaLocation W43770114541 @default.
• W4377011454 hasConcept C108170787 @default.
• W4377011454 hasConcept C108759981 @default.
• W4377011454 hasConcept C144024400 @default.
• W4377011454 hasConcept C144133560 @default.
• W4377011454 hasConcept C160735492 @default.
• W4377011454 hasConcept C162324750 @default.
• W4377011454 hasConcept C2779703844 @default.
• W4377011454 hasConcept C36289849 @default.
• W4377011454 hasConcept C38652104 @default.
• W4377011454 hasConcept C41008148 @default.
• W4377011454 hasConcept C50522688 @default.
• W4377011454 hasConcept C512399662 @default.
• W4377011454 hasConcept C71924100 @default.
• W4377011454 hasConceptScore W4377011454C108170787 @default.
• W4377011454 hasConceptScore W4377011454C108759981 @default.
• W4377011454 hasConceptScore W4377011454C144024400 @default.
• W4377011454 hasConceptScore W4377011454C144133560 @default.
• W4377011454 hasConceptScore W4377011454C160735492 @default.
• W4377011454 hasConceptScore W4377011454C162324750 @default.
• W4377011454 hasConceptScore W4377011454C2779703844 @default.
• W4377011454 hasConceptScore W4377011454C36289849 @default.
• W4377011454 hasConceptScore W4377011454C38652104 @default.
• W4377011454 hasConceptScore W4377011454C41008148 @default.
• W4377011454 hasConceptScore W4377011454C50522688 @default.
• W4377011454 hasConceptScore W4377011454C512399662 @default.
• W4377011454 hasConceptScore W4377011454C71924100 @default.
• W4377011454 hasFunder F4320323716 @default.
• W4377011454 hasIssue "1" @default.
• W4377011454 hasLocation W43770114541 @default.
• W4377011454 hasLocation W43770114542 @default.
• W4377011454 hasLocation W43770114543 @default.
• W4377011454 hasOpenAccess W4377011454 @default.
• W4377011454 hasPrimaryLocation W43770114541 @default.
• W4377011454 hasRelatedWork W1983808260 @default.
• W4377011454 hasRelatedWork W2015525254 @default.
• W4377011454 hasRelatedWork W2060979858 @default.
• W4377011454 hasRelatedWork W2356800349 @default.
• W4377011454 hasRelatedWork W2465599251 @default.
• W4377011454 hasRelatedWork W2520496507 @default.
• W4377011454 hasRelatedWork W2801680358 @default.
• W4377011454 hasRelatedWork W292296262 @default.
• W4377011454 hasRelatedWork W4311332022 @default.
• W4377011454 hasRelatedWork W3126058828 @default.
• W4377011454 hasVolume "16" @default.
• W4377011454 isParatext "false" @default.
• W4377011454 isRetracted "false" @default.
• W4377011454 workType "article" @default.